The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48522-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K19350260 TSA198589-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 TSA198636-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 TSA198687-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 TSA198737-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 TSA198789-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 TSA198840-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 TSA198888-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 TSA198933-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 TSF399798-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 10.0 µM for 24.0 h 1 subfactor(s) TSF399801-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 0.37 µM for 24.0 h 1 subfactor(s) TSF399799-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 3.33 µM for 24.0 h 1 subfactor(s) TSF399800-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 1.11 µM for 24.0 h 1 subfactor(s) TSF399803-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 0.04 µM for 24.0 h 1 subfactor(s) TSF399802-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 0.125 µM for 24.0 h 1 subfactor(s) TSF400117-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 0.125 µM for 24.0 h 1 subfactor(s) TSF400113-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 10.0 µM for 24.0 h 1 subfactor(s) TSF400114-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 3.33 µM for 24.0 h 1 subfactor(s) TSF400115-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 1.11 µM for 24.0 h 1 subfactor(s) TSF400116-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 0.37 µM for 24.0 h 1 subfactor(s) TSF400118-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 0.04 µM for 24.0 h 1 subfactor(s) TSF400429-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 10.0 µM for 24.0 h 1 subfactor(s) TSF400431-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 1.11 µM for 24.0 h 1 subfactor(s) TSF400430-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 3.33 µM for 24.0 h 1 subfactor(s) TSF400432-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 0.37 µM for 24.0 h 1 subfactor(s) TSF400433-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 0.125 µM for 24.0 h 1 subfactor(s) TSF400434-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 0.04 µM for 24.0 h 1 subfactor(s) TSF400744-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 10.0 µM for 24.0 h 1 subfactor(s) TSF400745-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 3.33 µM for 24.0 h 1 subfactor(s) TSF400746-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 1.11 µM for 24.0 h 1 subfactor(s) TSF400747-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 0.37 µM for 24.0 h 1 subfactor(s) TSF400748-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 0.125 µM for 24.0 h 1 subfactor(s) TSF400749-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 0.04 µM for 24.0 h 1 subfactor(s) TSF401061-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 10.0 µM for 24.0 h 1 subfactor(s) TSF401062-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 3.33 µM for 24.0 h 1 subfactor(s) TSF401063-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 1.11 µM for 24.0 h 1 subfactor(s) TSF401064-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 0.37 µM for 24.0 h 1 subfactor(s) TSF401065-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 0.125 µM for 24.0 h 1 subfactor(s) TSF401066-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 0.04 µM for 24.0 h 1 subfactor(s) TSF401379-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 10.0 µM for 24.0 h 1 subfactor(s) TSF401382-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 0.37 µM for 24.0 h 1 subfactor(s) TSF401380-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 3.33 µM for 24.0 h 1 subfactor(s) TSF401381-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 1.11 µM for 24.0 h 1 subfactor(s) TSF401383-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 0.125 µM for 24.0 h 1 subfactor(s) TSF401384-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 0.04 µM for 24.0 h 1 subfactor(s) TSF401698-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 10.0 µM for 24.0 h 1 subfactor(s) TSF401699-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 3.33 µM for 24.0 h 1 subfactor(s) TSF401700-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 1.11 µM for 24.0 h 1 subfactor(s) TSF401701-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 0.37 µM for 24.0 h 1 subfactor(s) TSF401702-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 0.125 µM for 24.0 h 1 subfactor(s) TSF401703-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 0.04 µM for 24.0 h 1 subfactor(s) TSF402012-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 10.0 µM for 24.0 h 1 subfactor(s) TSF402013-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 3.33 µM for 24.0 h 1 subfactor(s) TSF402016-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 0.125 µM for 24.0 h 1 subfactor(s) TSF402014-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 1.11 µM for 24.0 h 1 subfactor(s) TSF402015-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 0.37 µM for 24.0 h 1 subfactor(s) TSF402017-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 0.04 µM for 24.0 h 1 subfactor(s) TSS399806-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 10.0 µM for 24.0 h TSS399809-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 0.37 µM for 24.0 h TSS399807-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 3.33 µM for 24.0 h TSS399808-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 1.11 µM for 24.0 h TSS399811-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 0.04 µM for 24.0 h TSS399810-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K19350260 0.125 µM for 24.0 h TSS400125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 0.125 µM for 24.0 h TSS400121-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 10.0 µM for 24.0 h TSS400122-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 3.33 µM for 24.0 h TSS400123-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 1.11 µM for 24.0 h TSS400124-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 0.37 µM for 24.0 h TSS400126-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K19350260 0.04 µM for 24.0 h TSS400437-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 10.0 µM for 24.0 h TSS400439-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 1.11 µM for 24.0 h TSS400438-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 3.33 µM for 24.0 h TSS400440-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 0.37 µM for 24.0 h TSS400441-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 0.125 µM for 24.0 h TSS400442-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K19350260 0.04 µM for 24.0 h TSS400752-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 10.0 µM for 24.0 h TSS400753-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 3.33 µM for 24.0 h TSS400754-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 1.11 µM for 24.0 h TSS400755-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 0.37 µM for 24.0 h TSS400756-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 0.125 µM for 24.0 h TSS400757-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K19350260 0.04 µM for 24.0 h TSS401069-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 10.0 µM for 24.0 h TSS401070-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 3.33 µM for 24.0 h TSS401071-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 1.11 µM for 24.0 h TSS401072-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 0.37 µM for 24.0 h TSS401073-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 0.125 µM for 24.0 h TSS401074-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K19350260 0.04 µM for 24.0 h TSS401387-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 10.0 µM for 24.0 h TSS401390-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 0.37 µM for 24.0 h TSS401388-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 3.33 µM for 24.0 h TSS401389-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 1.11 µM for 24.0 h TSS401391-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 0.125 µM for 24.0 h TSS401392-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K19350260 0.04 µM for 24.0 h TSS401706-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 10.0 µM for 24.0 h TSS401707-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 3.33 µM for 24.0 h TSS401708-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 1.11 µM for 24.0 h TSS401709-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 0.37 µM for 24.0 h TSS401710-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 0.125 µM for 24.0 h TSS401711-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K19350260 0.04 µM for 24.0 h TSS402020-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 10.0 µM for 24.0 h TSS402021-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 3.33 µM for 24.0 h TSS402024-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 0.125 µM for 24.0 h TSS402022-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 1.11 µM for 24.0 h TSS402023-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 0.37 µM for 24.0 h TSS402025-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K19350260 0.04 µM for 24.0 h
TSP48522 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K19350260
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided